Login Register
icon_bulk_orderBulk order Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Non SARS-Cov-2 Kits > TNF-alpha > CEA-C010

ClinMax™ Human TNF-α ELISA Kit

For research use only.
This product is still under development. Please contact us if you have interest in this product. We will accelerate the development process accordingly and reserve this product for you as request.
  • Background
    ClinMax™ Human TNF-α Quantitative ELISA Kit is designed to quantitate human TNF-α that is present in complex biological matrices, such as human serum, plasma, buffered solution, or cell culture. Tumor necrosis factor alpha (TNF-alpha), is the prototypic cytokine of the TNF superfamily, and is a multifunctional molecule involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. TNF-alpha protein is produced mainly by macrophages, and large amounts of this cytokine are released in response to lipopolysaccharide, other bacterial products, and Interleukin-1 (IL-1). TNF-alpha is involved in fighting against the tumorigenesis, thus, is regarded as a molecular insight in cancer treatment.

  • Application
    This immunoassay is designed to quantitate human TNF-α that is present in human serum, plasma, buffered solution, or cell culture. It has been calibrated against a highly purified human TNF-α and is evaluated with standard from NIBSC/WHO. Reference Reagent TNF-α (Human, rDNA derived) NIBSC code: 12/154.

    It is for research use only.

  • Storage
    The unopened kit is stable for 12 months from the date of manufacture if stored at 2°C to 8°C.

    The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Assay Principles
     TNF-alpha Assay Principles

Comments (0)

Price(USD) : $498.00

Request GMP Version

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:51 Details
  • Number of Drugs in Clinical Trials:65 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message